Skip Navigation


Rheumatology Advance Access originally published online on August 18, 2009
Rheumatology 2009 48(11):1461-1462; doi:10.1093/rheumatology/kep241
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/11/1461    most recent
kep241v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schiffmann, A.
Right arrow Articles by Morel, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiffmann, A.
Right arrow Articles by Morel, J.
Related Collections
Right arrow Pharmacology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Mesenteric and splenic cat-scratch disease during etanercept therapy

Aurélie Schiffmann1, Yves Marie Pers1, Cédric Lukas1, Bernard Combe1 and Jacques Morel1

1Immuno-rhumatologie, Hopital Lapeyronie, Montpellier, France

Correspondence to: Aurélie Schiffmann, CHU Montpellier - Immuno-rhumatologie, Hopital Lapeyronie 371 Ave Doyen Gaston Giraud, Montpellier 34295, France. E-mail: aschiff@voila.fr

The first 10% of the full text of this article appears below.

SIR, Cat-scratch disease (CSD) is a benign infectious disease caused by Bartonella henselae, and generally seen among children and young adults. Disseminated infection with extended granulomatous lymphadenopathy and visceral involvement is well known in immuno-deficient patients. We report a case of a systemic CSD with mesenteric lymphadenopathy and splenic involvement in a patient taking etanercept to treat PsA.

A 51-year-old man was admitted to hospital with an elevated fever for 1 week. He had a history of PsA treated with etanercept for 2 years. Two days . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?